| Genomic Medicine |
1 |
1 |
| Biologic Therapy |
0 |
0.98 |
| Gene Therapy |
0 |
0.99 |
| Grant |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.21 |
| Medicaid |
0 |
0.21 |
| Skin Cancer |
0 |
0.19 |
| Squamous Cell Carcinoma |
0 |
0.15 |
| Biomedical Technology |
0 |
0.14 |
| Cancer |
0 |
0.14 |
| Neuroendocrine Tumor |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.12 |
| Sickle Cell Anemia |
0 |
0.1 |
| Blood |
0 |
0.07 |
| Child |
0 |
0.07 |
| Epidermolysis Bullosa |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Hand |
0 |
0.07 |
| Health Plans |
0 |
0.07 |
| Health Policy |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Herpes Simplex |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| I-Cell Disease |
0 |
0.07 |
| Lung |
0 |
0.07 |
| Lysosomal Storage Disease |
0 |
0.07 |
| Massachusetts |
0 |
0.07 |
| Medical Innovations |
0 |
0.07 |
| Wound |
0 |
0.07 |
| Wound Management |
0 |
0.07 |